Proposed EU NGT legislation in light of plant genetic variation
Plant Biotechnology Journal · 2025-10 · 23 (10) · 4261-4270
DOI: 10.1111/pbi.70228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plant Biotechnology Journal, online erschienen am 30.06.2025. Verfasst von Alan H Schulman und 6 weiteren Autor:innen. Beteiligte Einrichtung: HiLife Institute of Biotechnology and Viikki Plant Science Centre (ViPS), University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Genetic Variation, Plant Breeding, Genome, Plant, Genomics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jane ja Aatos Erkon Säätiö.
Abstract (Originalsprache)
The European Commission (EC) proposal for New Genomic Techniques (NGTs) of July 2023 specifies that Category 1 NGT (NGT1) plants, which are considered equivalent to conventional plants, that is those obtainable by conventional plant breeding or mutagenesis, may differ from the recipient or parental plant by no more than 20 insertions, which cannot be longer than 20 bp; deletions can be no more than 20 but of any size. Here, we examine the proposed 20/20 NGT1 limit against the background of the theoretical considerations and older data used to frame it and in light of recent data from highly contiguous long‐read assemblies for reference genomes and pangenomes. We find that current genomic data indicate that natural variation in germplasm used by breeders is much greater than earlier understood and that both conventional breeding and mutagenesis can introduce genomic changes that are both more extensive in size and more frequent than the NGT Category 1 ‘20 insertions of maximum 20 bp’ limit would allow. Furthermore, natural variation also scales with genome size and complexity, a factor not considered in the EC proposal. We conclude that the proposed cut‐offs under which an NGT plant is considered equivalent to conventional plants do not align with what is observed in nature, conventional breeding and mutagenesis. Updating the 20/20 rule to broader limits would facilitate breeding for climate resilience, farming sustainability and nutritional security, while ensuring that NGT1 plants are equivalent to conventional ones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- HiLife Institute of Biotechnology and Viikki Plant Science Centre (ViPS), University of Helsinki, Helsinki, Finland.
- Production Systems, Natural Resources Institute Finland (LUKE), Helsinki, Finland.
- Julius Kuehn Institute (JKI) - Federal Research Centre for Cultivated Plants, Institute for Biosafety in Plant Biotechnology, Quedlinburg, Saxony-Anhalt, Germany.
- Plant Breeding, Wageningen University & Research, Wageningen, The Netherlands.
- Department of Plant Biology, Swedish University of Agricultural Science, The Linnean Centre for Plant Biology, Uppsala, Sweden.
- Faculty of Biosciences, Department of Plant Sciences, Norwegian University of Life Sciences (NMBU), Ås, Norway.
ORCID-Profile: Alan H Schulman, Marinus J M Smulders, Ralf Wilhelm
Förderung
- Jane ja Aatos Erkon Säätiö
Zitieren
APA
Schulman, A. H., Hartung, F., Smulders, M. J. M., Sundström, J. F., Wilhelm, R., Rognli, O. A., & Metzlaff, K. (2025). Proposed EU NGT legislation in light of plant genetic variation. Plant Biotechnology Journal, 23(10), 4261-4270. https://doi.org/10.1111/pbi.70228
Vancouver
Schulman AH, Hartung F, Smulders MJM, Sundström JF, Wilhelm R, Rognli OA, et al. Proposed EU NGT legislation in light of plant genetic variation. Plant Biotechnology Journal. 2025;23(10):4261-4270. doi:10.1111/pbi.70228
BibTeX
@article{Schulman2025,
author = {Schulman, Alan H and Hartung, Frank and Smulders, Marinus J M and Sundström, Jens F and Wilhelm, Ralf and Rognli, Odd Arne and Metzlaff, Karin},
title = {Proposed EU NGT legislation in light of plant genetic variation},
journal = {Plant Biotechnology Journal},
year = {2025},
volume = {23},
number = {10},
pages = {4261--4270},
doi = {10.1111/pbi.70228}
}
EUVIMED